Calithera Biosciences, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Calithera Biosciences, Inc. has filed 530 SEC EDGAR filings since 16 Jul 2010

SEC filing history

Showing 276-300 of 530 matching filings.

Per page
25
Current page
12
8-K File 001-36644

8-K

Filing date
07 Aug 2018
Reporting date
07 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36644

8-K

Filing date
05 Jun 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36644

CT ORDER filing

Filing date
10 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36644

FORM 8-K

Filing date
10 May 2018
Reporting date
10 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36644

CT ORDER filing

Filing date
01 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36644

DEFINITIVE ADDITIONAL MATERIALS

Filing date
10 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36644

DEFINITIVE PROXY STATEMENT

Filing date
10 Apr 2018
Reporting date
31 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Apr 2018
Reporting date
03 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-223533

S-8

Filing date
08 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36644

FORM 8-K

Filing date
08 Mar 2018
Reporting date
08 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2018
Reporting date
02 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
06 Mar 2018
Reporting date
20 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2018
Reporting date
02 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
06 Mar 2018
Reporting date
01 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Feb 2018
Reporting date
23 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .